Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Regulation of the human protein S gene promoter by liver enriched transcription factors.

Hall AJ, Peake IR, Winship PR.

Br J Haematol. 2006 Nov;135(4):538-46.

PMID:
17061980
2.
3.

Factors participating in the liver-specific expression of the human apolipoprotein A-II gene and their significance for transcription.

Cardot P, Chambaz J, Kardassis D, Cladaras C, Zannis VI.

Biochemistry. 1993 Sep 7;32(35):9080-93.

PMID:
8369280
4.

Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter.

Song CS, Jung MH, Kim SC, Hassan T, Roy AK, Chatterjee B.

J Biol Chem. 1998 Aug 21;273(34):21856-66.

5.

Characterization of transcriptional regulatory elements in the promoter region of the murine blood coagulation factor VII gene.

Stauffer DR, Chukwumezie BN, Wilberding JA, Rosen ED, Castellino FJ.

J Biol Chem. 1998 Jan 23;273(4):2277-87.

6.
7.

Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha.

Jung D, Hagenbuch B, Gresh L, Pontoglio M, Meier PJ, Kullak-Ublick GA.

J Biol Chem. 2001 Oct 5;276(40):37206-14. Epub 2001 Aug 1.

8.

Molecular characterization of senescence marker protein-30 gene promoter: identification of repressor elements and functional nuclear factor binding sites.

Rath B, Pandey RS, Debata PR, Maruyama N, Supakar PC.

BMC Mol Biol. 2008 Apr 29;9:43. doi: 10.1186/1471-2199-9-43.

9.

Tissue specific differences in the regulation of the UDP glucuronosyltransferase 2B17 gene promoter.

Gregory PA, Hansen AJ, Mackenzie PI.

Pharmacogenetics. 2000 Dec;10(9):809-20.

PMID:
11191885
10.
11.

The human multidrug resistance protein 2 gene: functional characterization of the 5'-flanking region and expression in hepatic cells.

Tanaka T, Uchiumi T, Hinoshita E, Inokuchi A, Toh S, Wada M, Takano H, Kohno K, Kuwano M.

Hepatology. 1999 Dec;30(6):1507-12.

PMID:
10573531
12.

Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.

Klick DE, Shadley JD, Hines RN.

Biochem Pharmacol. 2008 Jul 15;76(2):268-78. doi: 10.1016/j.bcp.2008.05.002. Epub 2008 May 7.

PMID:
18555208
13.

Identification of positive and negative regulatory elements of the human cytochrome P4501A2 (CYP1A2) gene.

Chung I, Bresnick E.

Arch Biochem Biophys. 1997 Feb 15;338(2):220-6.

PMID:
9028875
14.

In vivo functional characterization of the aldolase B gene enhancer.

Gregori C, Porteu A, Mitchell C, Kahn A, Pichard AL.

J Biol Chem. 2002 Aug 9;277(32):28618-23. Epub 2002 May 28.

15.

Hepatocyte nuclear factor 4 (HNF4) binding sites in the salmon HNF1 promoter.

Deryckere F, McNair A, Gannon F.

Gene. 1996 Oct 10;175(1-2):35-41.

PMID:
8917073
17.

Binding of a liver-specific factor to the human albumin gene promoter and enhancer.

Frain M, Hardon E, Ciliberto G, Sala-Trepat JM.

Mol Cell Biol. 1990 Mar;10(3):991-9.

18.

Nuclear factor 1 family members interact with hepatocyte nuclear factor 1alpha to synergistically activate L-type pyruvate kinase gene transcription.

Satoh S, Noaki T, Ishigure T, Osada S, Imagawa M, Miura N, Yamada K, Noguchi T.

J Biol Chem. 2005 Dec 2;280(48):39827-34. Epub 2005 Oct 4.

20.

Expression of the alpha7 isoform of hepatocyte nuclear factor (HNF) 4 is activated by HNF6/OC-2 and HNF1 and repressed by HNF4alpha1 in the liver.

Briançon N, Bailly A, Clotman F, Jacquemin P, Lemaigre FP, Weiss MC.

J Biol Chem. 2004 Aug 6;279(32):33398-408. Epub 2004 May 24.

Supplemental Content

Support Center